Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematosus

Journal of Rheumatology

Volumn 44, Issue 7, 2017, Pages 1024-1031

  Kasturi, Shanthini ^a   Szymonifka, Jackie ^a   Burket, Jayme C ^b   Berman, Jessica R ^a   Kirou, Kyriakos A ^a   Levine, Alana B ^a   Sammaritano, Lisa R ^a   Mandl, Lisa A ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Hospital for Special Surgery   (France)

Author keywords

Patient outcome assessment; Quality of life; Systemic lupus erythematosus; Validation study

Indexed keywords

ADULT; ANGER; ANXIETY; ARTICLE; COGNITION; CONSTRUCT VALIDITY; DEPRESSION; DISEASE ACTIVITY; FATIGUE; FEMALE; HUMAN; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MALE; PATIENT MOBILITY; PRIORITY JOURNAL; SLEEP DISORDER; SOCIAL BEHAVIOR; SOCIAL PARTICIPATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TEST RETEST RELIABILITY; AGED; MIDDLE AGED; PATIENT SATISFACTION; PATIENT-REPORTED OUTCOME; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SELF REPORT; SEVERITY OF ILLNESS INDEX; VALIDATION STUDY; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PATIENT REPORTED OUTCOME MEASURES; PATIENT SATISFACTION; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SELF REPORT; SEVERITY OF ILLNESS INDEX; SOCIAL PARTICIPATION; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85021828911     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.161202     Document Type: Article

References (42)

1. Urowitz MB, Gladman DD, Tom BD, Ibaez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol 2008;35:2152-8.
2. Alarcón GS, McGwin G, Brooks K, Roseman JM, Fessler BJ, Sanchez ML, et al; LUMINA Study Group. Lupus in minority populations: nature versus nurture. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: A comparison of physician and patient visual analog scale scores. Arthritis Rheum 2002;47:408-13.
3. McElhone K, Abbott J, Teh LS. A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-43.
4. U.S. Food and Drug Administration. Guidance for industry systemic lupus erythematosus - developing medical products for treatment. [Internet. Accessed March 20, 2017.] Available from: www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm072063.pdf
5. European Medical League. Guideline on clinical investigation of medicinal products for the treatment of systemic lupus erythematosus and lupus nephritis. [Internet. Accessed March 20, 2017.] Available from: www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2015/03/WC500184889.pdf
6. Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology. Lupus 2000;9:322-7.
7. Castelino M, Abbott J, McElhone K, Teh LS. Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: A review of the literature. Rheumatology 2013;52:684-96.
8. Holloway L, Humphrey L, Heron L, Pilling C, Kitchen H, Højbjerre L, et al. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: A review of content validity, face validity and psychometric performance. Health Qual Life Outcomes 2014;12:116.
9. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
10. Kuriya B, Gladman DD, Ibaez D, Urowitz MB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum 2008;59:181-5.
11. Touma Z, Gladman DD, Ibaez D, Urowitz MB. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus? J Rheumatol 2011;38:1898-905.
12. Devilliers H, Amoura Z, Besancenot JF, Bonnotte B, Pasquali JL, Wahl D, et al. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE. Rheumatology 2015;54:940-9.
13. Danoff-Burg S, Friedberg F. Unmet needs of patients with systemic lupus erythematosus. Behav Med 2009;35:5-13.
14. McElhone K, Abbott J, Gray J, Williams A, Teh LS. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: A qualitative study. Lupus 2010;19:1640-7.
15. Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, et al. Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 2012; 42:56-65.
16. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 2007;57:972-9.
17. HealthMeasures. Intro to PROMIS. [Internet. Accessed March 20, 2017.] Available from: www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis
18. Hochberg MC. Updating the American College of Rheumatology Revised criteria for the classification of Systemic Lupus Erythematosus. Arthritis Rheum 1997;40:1725.
19. Ow YL, Thumboo J, Cella D, Cheung YB, Yong Fong K, Wee HL. Domains of health-related quality of life important and relevant to multiethnic English-speaking Asian systemic lupus erythematosus patients: A focus group study. Arthritis Care Res 2011;63:899-908.
20. HealthMeasures. List of adult measures. [Internet. Accessed March 20, 2017.] Available from: www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis/list-of-adult-measures
21. Jolly M, Pickard AS, Wilke C, Mikolaitis RA, Teh LS, McElhone K, et al. Lupus-specific health outcome measure for US patients: The LupusQoL-US version. Ann Rheum Dis 2010;69:29-33.
22. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al; OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
23. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 1996;39:363-9.
24. Campbell D, Fiske D. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959;56:81-105.
25. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
26. Hays R, Revicki DA. Reliability and validity (including responsiveness). In: Fayers P, Hays R, eds. Assessing quality of life in clinical trials. New York: Oxford University Press; 2005:25-39.
27. Lai JS, Beaumont JL, Jensen SE, Kaiser K, Van Brunt DL, Kao AH, et al. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clin Rheumatol 2017;36:555-62.
28. Katz P, Pedro S, Michaud K. Performance of the PROMIS 29-Item Profile in rheumatoid arthritis, osteoarthritis, fibromyalgia, and systemic lupus erythematosus. Arthritis Care Res 2016 Dec 28 (E-pub ahead of print).
29. Mahieu MA, Ahn GE, Chmiel JS, Dunlop DD, Helenowski IB, Semanik P, et al. Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus. Lupus 2016;25:1190-9.
30. Brandon TG, Becker BD, Bevans KB, Weiss PF. Patient-Reported Outcomes Measurement Information System tools for collecting patient-reported outcomes in children with juvenile arthritis. Arthritis Care Res 2017;69:393-402.
31. Jones JT, Carle AC, Wootton J, Liberio B, Lee J, Schanberg LE, et al. Validation of Patient-Reported Outcomes Measurement Information System short forms for use in childhood-onset systemic lupus erythematosus. Arthritis Care Res 2017;69:133-42.
32. Khanna D, Krishnan E, Dewitt EM, Khanna PP, Spiegel B, Hays RD. The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res 2011;63 Suppl 11:S486-90.
33. Jolly M. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses? J Rheumatol 2005;32:1706-8.
34. Khanna D, Maranian P, Rothrock N, Cella D, Gershon R, Khanna PP, et al. Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic. Value Health 2012;15:128-34.
35. Bartlett SJ, Orbai AM, Duncan T, DeLeon E, Ruffing V, Clegg-Smith K, et al. Reliability and validity of selected PROMIS measures in people with rheumatoid arthritis. PLoS One 2015;10:e0138543.
36. McElhone K, Abbott J, Sutton C, Mullen M, Lanyon P, Rahman A, et al. Sensitivity to change and minimal important differences of the LupusQoL in patients with systemic lupus erythematosus. Arthritis Care Res 2016;68:1505-13.
37. Gladman DD, Urowitz MB, Ong A, Gough J, MacKinnon A. Lack of correlation among the 3 outcomes describing SLE: disease activity, damage and quality of life. Clin Exp Rheumatol 1996;14:305-8.
38. McElhone K, Castelino M, Abbott J, Bruce IN, Ahmad Y, Shelmerdine J, et al. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. J Rheumatol 2010;37:2273-9.
39. Thanou A, Merrill JT. Top 10 things to know about lupus activity measures. Curr Rheumatol Rep 2013;15:334.
40. Lavallee DC, Chenok KE, Love RM, Petersen C, Holve E, Segal CD, et al. Incorporating patient-reported outcomes into health care to engage patients and enhance care. Health Aff 2016;35:575-82.
41. Basch E. Patient-reported outcomes -harnessing patients' voices to improve clinical care. N Engl J Med 2017;376:105-8.
42. HealthMeasures. Available translations. [Internet. Accessed March 20, 2017.] Available from: www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis/available-translations